Equities

Surgical Innovations Group PLC

SUN:LSE

Surgical Innovations Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)0.50
  • Today's Change0.00 / 0.00%
  • Shares traded5.25m
  • 1 Year change-74.36%
  • Beta0.4823
Data delayed at least 20 minutes, as of May 02 2024 16:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Surgical Innovations Group Plc is a holding company that is involved in the design, manufacture, sale and distribution of quality medical products, primarily for use in minimally invasive surgery. In addition, the Company designs and develops medical devices for original equipment manufacturer (OEM) partners. The Company’s segments include SI Brand, OEM, and Distribution. The SI Brand segment is engaged in the research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third party medical device companies through their own label or co-branding. It also includes research, development, manufacture, and sale of minimally invasive technology products for precision engineering applications. The Distribution segment is engaged in the distribution of specialist medical products sold by Elemental Healthcare Ltd.

  • Revenue in GBP (TTM)12.01m
  • Net income in GBP-509.00k
  • Incorporated1988
  • Employees90.00
  • Location
    Surgical Innovations Group PLCClayton Wood House, 6 Clayton Wood BankLEEDS LS16 6QZUnited KingdomGBR
  • Phone+44 113 230 7597
  • Fax+44 113 230 7598
  • Websitehttps://www.sigroupplc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Image Scan Holdings Plc2.96m123.94k1.88m14.0015.111.248.140.63510.00090.00090.02170.01111.223.134.66211,637.905.12-1.157.77-1.7748.4451.364.18-1.012.03--0.098--47.98-3.08145.65--40.19--
Deltex Medical Group plc1.78m-1.28m2.37m37.00--0.7018--1.33-0.0012-0.00120.00150.00180.29740.84715.6148,000.00-21.47-14.66-29.13-21.8163.3471.84-72.18-32.931.13-2.980.3793---28.44-18.55-11.97--9.78--
Truspine Technologies PLC0.00-471.89k2.37m1.00--0.831-----0.004-0.0040.000.02050.00----0.00-13.14-21.97-16.58-26.49-----------32.310.0984------23.29--21.72--
Surgical Innovations Group Plc12.01m-509.00k4.66m90.00--0.444918.810.3882-0.0005-0.00050.01290.01120.80322.855.89---3.40-8.19-4.18-9.9428.7032.51-4.24-13.311.23-4.450.1368--5.941.84-292.80--7.20--
Myhealthchecked PLC14.95m189.00k5.20m15.0026.950.608315.710.3480.00370.00370.28850.16441.265.817.95996,400.001.59-20.092.21-28.2327.7922.621.26-13.423.53--0.0047--36.26190.36-24.30---12.80--
Rua Life Sciences PLC1.87m-1.87m6.67m40.00--0.6387--3.57-0.0843-0.08430.08430.16830.32933.264.8046,725.00-32.95-25.97-36.33-28.2681.97---100.05-110.532.40-61.710.1065--34.0940.083.10--94.82--
Advanced Oncotherapy PLC0.00-32.60m9.50m174.00--0.1306-----0.0819-0.08190.000.1340.000.00--0.00-23.34-25.83-29.05-30.15--------0.1293-4.060.4968-------16.57---0.8064--
Ondine Biomedical Inc467.25k-10.87m11.56m43.00--4.15--24.75-0.0558-0.05580.00240.01240.04920.35845.5410,866.37-114.33---135.98--49.00---2,326.12--1.93--0.1961---75.17--61.32------
Inspiration Healthcare Group PLC41.08m-550.00k11.60m210.00--0.32936.890.2824-0.0081-0.00810.6030.51630.78792.324.76195,619.00-1.056.14-1.257.6045.5947.42-1.346.001.50-0.12890.2317--0.445821.62-93.58-25.9752.54--
Belluscura PLC960.12k-7.99m11.93m24.00--0.4875--12.43-0.0645-0.06450.00780.14830.04450.21970.309940,005.16-36.98-35.98-40.59-39.17-32.24-40.01-831.69-838.024.17-3.430.00--232.6231.09-56.38--30.90--
Data as of May 02 2024. Currency figures normalised to Surgical Innovations Group PLC's reporting currency: UK Pound GBX

Institutional shareholders

47.20%Per cent of shares held by top holders
HolderShares% Held
Liontrust Investment Partners LLPas of 29 Feb 202477.25m8.28%
BGF Investment Management Ltd.as of 31 Dec 202270.73m7.58%
Healthinvest Partners ABas of 19 Apr 202463.93m6.85%
Stonehage Fleming Investment Management Ltd.as of 31 Dec 202258.09m6.23%
Ruffer LLPas of 17 Apr 202443.61m4.68%
Hargreaves Lansdown Asset Management Ltd.as of 31 Dec 202237.25m3.99%
Interactive Investor Services Ltd.as of 31 Dec 202235.14m3.77%
Investec Wealth & Investment Ltd.as of 01 Apr 202426.79m2.87%
Unicorn Asset Management Ltd.as of 01 Apr 202419.14m2.05%
IG Markets Ltd.as of 01 Apr 20248.35m0.90%
More ▼
Data from 31 Dec 2023 - 12 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.